Abstract
In experiments devised to compare the neutralizing action of normal adult human sera on different strains of poliomyelitis virus, and to fill in certain gaps in our series of neutralization tests with different strains of virus on different types of cases in different age groups, we have made the following observations. 1. The difference between two human and two passage strains of the virus when tested by this method amounted to about 25 per cent, and there was less power in normal adult sera to neutralize human than passage strains of virus. 2. The differences between the two human strains amounted to 15 per cent, and between the two passage strains to 8 per cent, the last figure falling within the limits of the experimental error of the method. The extent to which these findings affect certain concepts with regard to the epidemiology of poliomyelitis based on passage strain neutralization experiments cannot be determined from the data presented in this paper, except that they more or less confirm the view previously derived from passage strain experiments, that 70 to 95 per cent of normal urban adults possess in their blood, substance which neutralizes poliomyelitis virus in a given amount. However, certain other indications appear when the present results are supplemented by those we have previously obtained (25). Primarily, we have found no relation between the clinical acquisition of poliomyelitis and the presence of substance in the serum which neutralizes a passage strain of poliomyelitis virus. With a passage strain the results seem rather to bear a closer relationship to age than to illness. With a human strain we have obtained results in which there is some evidence, shown only in the juvenile group, that acquisition of the clinical disease is accompanied by the appearance of antiviral properties in the blood.
Full Text
The Full Text of this article is available as a PDF (913.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aycock W. L., Kramer S. D. IMMUNITY TO POLIOMYELITIS IN MOTHERS AND THE NEWBORN AS SHOWN BY THE NEUTRALIZATION TEST. J Exp Med. 1930 Sep 30;52(4):457–464. doi: 10.1084/jem.52.4.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paul J. R., Trask J. D. A COMPARATIVE STUDY OF RECENTLY ISOLATED HUMAN STRAINS AND A PASSAGE STRAIN OF POLIOMYELITIS VIRUS. J Exp Med. 1933 Oct 31;58(5):513–529. doi: 10.1084/jem.58.5.513. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paul J. R., Trask J. D. THE DETECTION OF POLIOMYELITIS VIRUS IN SO CALLED ABORTIVE TYPES OF THE DISEASE. J Exp Med. 1932 Aug 31;56(3):319–343. doi: 10.1084/jem.56.3.319. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stewart F. W., Rhoads C. P. INTRADERMAL VERSUS SUBCUTANEOUS IMMUNIZATION OF MONKEYS AGAINST POLIOMYELITIS. J Exp Med. 1929 May 31;49(6):959–973. doi: 10.1084/jem.49.6.959. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weyer E. R., Park W. H., Banzhaf E. J. A POTENT ANTIPOLIOMYELITIC HORSE SERUM CONCENTRATE AND ITS EXPERIMENTAL USE IN INFECTED MONKEYS. J Exp Med. 1931 Mar 31;53(4):553–566. doi: 10.1084/jem.53.4.553. [DOI] [PMC free article] [PubMed] [Google Scholar]